ORPEA: Changes in Shareholders’ Holdings
22 Gennaio 2020 - 7:00AM
Business Wire
Regulatory News:
The ORPEA Group (Paris:ORP), a world leader in long-term care
(nursing homes, post-acute and rehabilitation hospitals,
psychiatric hospitals, and home care services), announce its new
shareholding structure as of 22nd of January 2020 following the
sale of Dr Marian stake.
Changes in ORPEA shareholding structure
31.12.20191
22.01.2020
Number of shares
% capital
Number of shares
% capital
CPPIB
9,374,186
14.5%
9,374,186
14.5%
Dr. Marian
4,080,420
6.3%
0
0.0%
FFP Invest
3,261,353
5.0%
3,261,353
5.0%
Sofina SA
1,298,000
2.0%
1,298,000
2.0%
Treasury shares
45,142
0.1%
45,1421
0.1%
Free Float
46,556,736
72.1%
50,637,156
78.4%
TOTAL
64,615,837
100.0%
64,615,837
100.0%
The transfer of ownership of Dr Marian’s entire stake was
carried out through Accelerated Book Building on 21 January
2020.
This transaction, relating to 4,080,420 shares, i.e. 6.3% of the
share capital, was carried out at a price of €111.85 per share,
i.e. at a discount of 4.6% compared with the closing price on 21
January 2020.
The success of this operation was due to a steady profitable
growth strategy focused on long-term value creation applied by
ORPEA’s teams for the past 30 years.
This transaction increases the free float and the shareholder
base and thus improves the share’s liquidity.
ORPEA would like to thank both the new and existing investors
who took part in this investment. The Group would like to take this
opportunity to reiterate with extreme confidence its growth
strategy to reinforce its position as a world leader in long-term
care which ensures its profitable growth over the short, medium and
long term.
Upcoming press release: full-year 2019
revenue 11 February 2020 after market close
About ORPEA (www.orpea-corp.com)
Founded in 1989, ORPEA is one of the major world leaders in
long-term care, with a network of 951 facilities comprising 96,677
beds (17,388 of which are under construction) across 16 countries,
which are divided into five clusters:
- France Benelux: 484 facilities/42,625 beds (of which 4,514 are
under construction)
- Central Europe: 238 facilities/25,419 beds (of which 4,389 are
under construction)
- Eastern Europe: 125 facilities/12,917 beds (of which 2,817 are
under construction)
- Iberian Peninsula/Latin America: 103 facilities/15,576 beds (of
which 5,668 are under construction)
- Rest of the world: 1 facility/140 beds
ORPEA is listed on Euronext Paris (ISIN code: FR0000184798) and
a constituent of the SBF 120, STOXX 600 Europe, MSCI Small Cap
Europe and CAC Mid 60 indices.
1 Based on information included on the list of registered
shareholders at 31.12.19
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200121006155/en/
Investor Relations ORPEA Steve Grobet Investor
Relations Director s.grobet@orpea.net
Hélène de Watteville Investor Relations Officer
h.dewatteville@orpea.net
Investor Relations NewCap Dusan Oresansky +33 (0)1
44 71 94 94 orpea@newcap.eu
Media Relations Image 7 Laurence Heilbronn +33
(0)1 53 70 74 64 lheilbronn@image7.fr
Grafico Azioni Orpea (EU:ORP)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Orpea (EU:ORP)
Storico
Da Apr 2023 a Apr 2024